Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,377-2,388 of 10,592
Drug study icon
CompletedNCT02133001

Intranasal Esketamine for depression

This study is completed in the United States. It is testing intranasal Esketamine for depression.

In United States
Depression, SuicidalityDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT00518323

Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia

This study is completed in the United States, in India, in Romania, .... It is testing Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia.

In United States
SchizophreniaDrugFrom 12 Years to 17 Years
Countries
United States, India, Romania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01094249

Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia

This study is completed in the United States. It is testing Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia.

In United States
Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Behavioral study icon
CompletedNCT00938301

Safety study of PF-04455242 in Bipolarity

This study is completed in the United States. It is testing PF-04455242 for Bipolarity.

In United States
Bipolarity, DepressionBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.